Possible mechanisms of homocysteine toxicity. Hyperhomotion, increases platelet aggregation, and acts on the coagcysteinemia is a risk factor for cardiovascular disease in the ulation cascade and fibrinolysis, directly inducing, or actgeneral population. In chronic renal failure (CRF), plasma ing in a synergistic manner with other risk factors in homocysteine levels rise when the glomerular filtration rate creating a prothrombotic environment. It activates coag-(GFR) is reduced 50%, and in uremia the majority of patients are hyperhomocysteinemic. The purpose of this study was to ulation factor V, X, and XII, along with decreased activareview possible mechanisms of homocysteine toxicity. Homotion of protein C and cell-surface thrombomodulin, and cysteine, a sulfur amino acid found in blood in micromolar conmodulation of tissue plasminogen activator binding to centrations, can have toxic effects through a handful of general its endothelial receptor, annexin II. possible mechanisms. These mechanisms include oxidative stress (through the production of reactive oxygen species), binding Proposed toxicity mechanisms are oxidation, nitrosyto nitric oxide, production of homocysteinylated/acylated prolation, homocysteinylation, and hypomethylation. It has teins, and accumulation of its precursor, S-adenosyl-homocysto be stressed that the different mechanisms of homocysteine, a potent inhibitor of transmethylation reactions. Methyltransferase inhibition actually occurs in CRF and in uremia, teine toxicity are not mutually exclusive. and can have several functional consequences.
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Oxidation
Thiols can auto-oxidize in the presence of transition Hyperhomocysteinemia is a strong predictor of cardiometal catalysts and molecular oxygen, leading to the vascular disease (CVD) in the general population [1] . A formation of reactive oxygen species (ROS). Homocysclear link between homocysteine and CVD was found teine can induce a pro-oxidant action in vitro through in monogenic diseases called, as a whole, homocystinhydrogen peroxide production during metal-catalyzed uria, in which plasma homocysteine concentration inoxidation, and, in the presence of nitric oxide, the supercreases several-fold (400 to 500 mol/L). More recently, oxide anion can form powerful oxidant peroxynitrite [3] . mild (Ͻ16 mol/L) hyperhomocysteinemia has been rec-Formation of ROS could lead to lipid peroxidation, ognized as a CVD risk factor in the general population, which initiates an inflammatory response and is involved and in a number of acquired conditions, such as chronic renal failure (CRF), where homocysteine levels can range in establishing foam cells, a key atherosclerotic lesion from moderate (16 to 30 mol/L) to intermediate (30 to component. Studies performed in vitro have shown both 100 mol/L). In a recent study, a population of 175 chronic a pro-oxidant and an antioxidant effect of homocysteine hemodialysis patients followed for 29 months showed on LDL oxidation. Thiols can function as anti-or proan increase in mortality rates, which was higher in the oxidants, depending on the physical location (intra-or patients with the highest homocysteine levels at baseline extracellular) of the oxidative damage occurring to lipo- [2] . Statistical adjustment for confounders and tradiproteins. Depending on the experimental condition, tional and nontraditional risk factors was performed.
homocysteine can both inhibit and promote LDL oxidation, and it has been speculated that its concentration MECHANISMS OF ACTION (low ϭ pro-oxidant, high ϭ anti-oxidant) determines which activity will prevail [4] . However, phosphatidyl-Hyperhomocysteinemia can be toxic for the endothecholine hydroperoxide, a product of lipid peroxidation, lium; it enhances vascular smooth muscle cell proliferaand P-selectin, a cell adhesion molecule and a marker of endothelial damage, did not change after a methionine load, suggesting that effects of homocysteine on endothelium are not mediated by oxidative stress mechanisms [5]. Clearly, more studies are necessary to elucidate the role of homocysteine on lipoprotein oxidation. Homocysteine can impair endothelial cell function, which can be monitored by the reduction in endothelium-derived flow-mediated vasodilation by either a methionine load in healthy individuals, or in hyperhomocysteinemic patients [6] [7] . Because of the protective effects exerted by administration of antioxidants such as vitamin C and E [8], and because of cell culture studies showing that homocysteine leads to considerable toxic effects mediated by ROS formation, it has been suggested that effects of homocysteine on endothelium occur via oxida- duces only negligible quantities of hydrogen peroxide (1:4000 mmol of hydrogen peroxide/mole of homocysteine), and only when catalyst metal ions are present. Hydrogen peroxide was measured with a sensitive fluostress may generate within vascular cells, but not necesrometric method. According to these authors, homocyssarily as a result of thiol oxidation [13] . In addition, perteine at micromolar concentrations does not act as a prohaps folates, other B vitamins, and vitamin C and E are oxidant but displays an antioxidant effect on cellular and protective via mechanisms independent of their homochemical systems.
cysteine-lowering or antioxidant effects. Importantly, only a small fraction of homocystine (the The mechanism of homocysteine binding to plasma prooxidized form of homocysteine, also termed homocysteins is important since this amino acid is mostly transteine homodimer) in blood is formed through a direct ported though circulation in this form. Despite the rather oxidative process, and albumin-bound homocysteine high binding capacity of plasma proteins for thiols, a reforms primarily through formation of an albumin thiodistribution of protein-bound thiols takes place during late anion (Fig. 1) . The investigators conclude that the hyperhomocysteinemia independently from any metabolic role of copper-catalyzed or ceruloplasmin-catalyzed aueffect. An example of the displacement of protein-bound toxidation of homocysteine is probably a minor process cysteine operated by homocysteine is given in Fig. 2 . Two major consequences arise from increasing homocysteine in circulation [11] [12] . It has been proposed that oxidative concentration in this in vitro system. After diafiltration Plasma proteins, incubated in the presence of homocysto remove free non-protein-bound thiols in the sample teine thiolactone, form spontaneously homocysteinynot added with homocysteine, the peak of this amino lated proteins, with complete disappearance of thiolacacid almost disappears from diafiltrate, confirming that tone from the medium after three hours. Consequences most homocysteine is bound to proteins (compare Fig. 2 of protein homocysteinylation are protein damage with A and C). In the sample incubated with homocysteine, an altered electrophoretic mobility, and loss of enzymatic the proportion of free (non-protein-bound) homocysactivity (with protein denaturation) in several model systeine increases significantly ( Fig. 2 B and D) . Proteintems, such as plasma proteins, methionyl tRNA synthebound homocysteine accounts for 99% and 68% of total, tase, tripsyn, lysin oxidase, etc. Normally, it is not possible in the samples incubated without and with, homocysto measure homocysteine thiolactone in blood, probably teine, respectively. Results shows that protein-bound because of its high reactivity and/or low concentration. cysteine and the dipeptide cysteine-glycine decrease in However, when there is an increase in blood homocysthe sample incubated with homocysteine, compared to teine, a parallel increase in homocysteinylated proteins the sample in the absence of homocysteine (Fig. 2 B can be observed. Protein homocysteinylation could be vs. 2 A). The percentage of protein-bound cysteine and one of the principal mediators of homocysteine toxicity, cysteine-glycine is 49% (cysteine) and 44% (cysteinehelping to determine structural and functional alterglycine) in the high-homocysteine sample, compared to ations at the molecular and cellular level [15] . 86% (cysteine) and 81% (cysteine-glycine) in the lowhomocysteine samples, respectively.
Hypomethylation These results, obtained in a cell-free system, suggest
An increase in plasma levels of homocysteine in uremic that displacement may play a significant contribution, patients leads to a rise in the intracellular concentration although in vivo effects due to metabolic adjustments of AdoHcy [16] . This thioether is the only homocysteine need to be considered in a general mechanism of action.
precursor and the natural inhibitor of all AdoMet-In favor of this interpretation is the reported existence dependent transmethylation reactions. The ratio [Adoof disulfide interchange in human serum albumin [11] Met]/[AdoHcy] is a good indicator of the normal flow ( Fig. 1) . Moreover, the situation described by our findof methyl groups transferred from the methyl donor to ings may cause an increased intracellular availability of methyl acceptors within the cell. The rise of AdoHcy free homocysteine. concentration in erythrocytes of uremic patients, which is not paralleled by a rise of AdoMet concentration, gives Nitrosylation way to a significant reduction of the [AdoMet]/[AdoHcy] Endothelial cells can detoxify homocysteine through ratio. This causes a significant impairment of AdoMetrelease of nitric oxide, with an accompanying increase dependent membrane protein carboxyl methylation rein Nos3 mRNA levels [3] . From the oxidation of homoaction, catalyzed by protein carboxyl methyltransferase cysteine with nitric oxide, S-nitroso-homocysteine for-(PCMT, EC 2.1.1.77). This ubiquitous methylation reacmation ensues. S-nitroso-homocysteine has vasodilatory tion is involved in the repair of molecular damage, repreand platelet antiaggregation properties, and does not sented by L-isoaspartyl residues, spontaneously occursupport hydrogen peroxide generation. This represents ring in proteins through deamidation of labile asparagine a protective mechanism against the adverse effects of residues. Several crucial transmethylation-dependent homocysteine. The scavenging effect of homocysteine is processes, in addition to protein repair in cells different overcome in chronic exposure to high homocysteine, from erythrocytes, can be affected by a reduction in the leading to a reduced production or availability of NO·,
[AdoMet]/[AdoHcy] ratio. It has been shown that an leading to unopposed oxidative injury mediated by homoincrease in plasma homocysteine is associated with paralcysteine and formation of peroxynitrite.
lel increases in plasma AdoHcy and lymphocyte DNA Homocysteine may affect glutathione peroxidase achypomethylation, evaluated by HpaII digestion and cytivity, thus altering the microenvironment in the propatosine-extension assay in normal women. Disruption of gation of ROS [14] . Endothelial glutathione peroxidase nonrandom DNA methylation pattern can lead to inapcatalyzes the reduction of hydrogen and lipid peroxides propriate gene expression and promotion of disease [17] . to the corresponding alcohol, and it prevents the oxida-In uremic patients, plasma levels of damaged proteins, tive inactivation of NO·. Homocysteine reduces mRNA that is, proteins containing the L-isoaspartyl residues, levels of glutathione peroxidase, indicating that the exare increased [18] . Folate treatment can lower, though pression of this enzyme protein is inhibited or downnot significantly, levels of damaged plasma proteins, regulated.
meaning that other toxins besides homocysteine have a Protein homocysteinylation/acylation role in protein damage [18] . Metabolic repercussions of folate administration, 15 A post-biosynthetic acylation of free amino groups in proteins is mediated by homocysteine thiolactone [15] . mg/day per os for two months, are to increase the eryth- of stable isotope labeling of methionine, measured whole [36] [37] 1998 body rates of methionine and homocysteine metabolism 
